Publications for Mariana Babayeva mariana.babayeva@touro.edu

Babayeva, M., Assefa, H., Basu, P., Chumki, S., & Loewy, Z. (2016). Marijuana compounds: A nonconventional approach to Parkinson’s disease therapy. Parkinson's Disease, 2016 [Article 1279042]. doi:10.1155/2016/1279042

Vysotski, S., Winzelberg, R., & Babayeva, M. (2016). Overcoming cancer multidrug resistance through inhibition of microparticles. GSTF International Journal of Advances in Medical Research, 1(4). This material can be found here.

Jiang, J. K., McCoy, J. G., Shen, M., LeClair, C. A., Huang, W., Negri, A., . . . Babayeva, M. (2014). A novel class of ion displacement ligands as antagonists of the αIIbβ3 receptor that limit conformational reorganization of the receptor. Bioorganic & Medicinal Chemistry Letters, 24(4), 1148-1153. doi:10.1016/j.bmcl.2013.12.122

Mullokandov, E., Ahn, J., Szalkiewicz, A., & Babayeva, M. (2014). Protein binding drug-drug interaction between warfarin and tizoxanide in human plasma. Austin Journal of Pharmacolology and Therapeutics, 2(7) [Article id1038]. This material can be found here.

White, M. P., Babayeva, M., Taft, D. R., & Maniar, M. (2013). Determination of intestinal permeability of rigosertib (ON 01910.Na, Estybon): Correlation with systemic exposure. Journal of Pharmacy and Pharmacology, 65(7), 960-969.  doi:10.1111/jphp.12057

Babayeva, M., Cox, S., White, M. P., & Taft, D. R. (2011). Renal excretion of apricitabine in rats: Ex vivo and in vivo studies. European Journal of Drug Metabolism and Pharmacokinetics, 36(3), 141-150. doi:10.1007/s13318-011-0038-9

Nakatani-Freshwater, T., Babayeva, M., Dontabhaktuni, A., & Taft, D. (2006). Effects of trimethoprim on the clearance of apricitabine, a deoxycytidine analog reverse transcriptase inhibitor, and lamivudine in the isolated perfused rat kidney. Journal of Pharmacology and Experimental Therapeutics 319(2), 941-947. doi:10.1124/jpet.106.108522